Elacestrant: a new FDA-approved SERD for the treatment of breast cancer
Neha Bhatia, Suresh Thareja
Topics & Concepts
Breast cancerClinical trialEstrogen receptorMedicineOncologyPharmacologyIn vivoCancerInternal medicineClinical researchHematologyPharmacokineticsBiologyBiotechnologyEstrogen and related hormone effectsAdvanced Breast Cancer TherapiesCancer therapeutics and mechanisms